body { -webkit-animation: none; -moz-animation: none; -ms-animation: none; animation: none }

EXPLORE!

FDA Approves Erzofri

425 Views

Emedinexus 23 April 2025

FDA has approved (paliperidone palmitate) extended-release injectable suspension, for treating schizophrenia in adults and for treating schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.

To comment on this article,
create a free account.

Already registered?

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.